Cargando…

Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability

BACKGROUND: Severe refractory asthma is a heterogeneous disease. We sought to determine statistical clusters from the British Thoracic Society Severe refractory Asthma Registry and to examine cluster-specific outcomes and stability. METHODS: Factor analysis and statistical cluster modelling was unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Newby, Chris, Heaney, Liam G., Menzies-Gow, Andrew, Niven, Rob M., Mansur, Adel, Bucknall, Christine, Chaudhuri, Rekha, Thompson, John, Burton, Paul, Brightling, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109965/
https://www.ncbi.nlm.nih.gov/pubmed/25058007
http://dx.doi.org/10.1371/journal.pone.0102987
_version_ 1782327941760286720
author Newby, Chris
Heaney, Liam G.
Menzies-Gow, Andrew
Niven, Rob M.
Mansur, Adel
Bucknall, Christine
Chaudhuri, Rekha
Thompson, John
Burton, Paul
Brightling, Chris
author_facet Newby, Chris
Heaney, Liam G.
Menzies-Gow, Andrew
Niven, Rob M.
Mansur, Adel
Bucknall, Christine
Chaudhuri, Rekha
Thompson, John
Burton, Paul
Brightling, Chris
author_sort Newby, Chris
collection PubMed
description BACKGROUND: Severe refractory asthma is a heterogeneous disease. We sought to determine statistical clusters from the British Thoracic Society Severe refractory Asthma Registry and to examine cluster-specific outcomes and stability. METHODS: Factor analysis and statistical cluster modelling was undertaken to determine the number of clusters and their membership (N = 349). Cluster-specific outcomes were assessed after a median follow-up of 3 years. A classifier was programmed to determine cluster stability and was validated in an independent cohort of new patients recruited to the registry (n = 245). FINDINGS: Five clusters were identified. Cluster 1 (34%) were atopic with early onset disease, cluster 2 (21%) were obese with late onset disease, cluster 3 (15%) had the least severe disease, cluster 4 (15%) were the eosinophilic with late onset disease and cluster 5 (15%) had significant fixed airflow obstruction. At follow-up, the proportion of subjects treated with oral corticosteroids increased in all groups with an increase in body mass index. Exacerbation frequency decreased significantly in clusters 1, 2 and 4 and was associated with a significant fall in the peripheral blood eosinophil count in clusters 2 and 4. Stability of cluster membership at follow-up was 52% for the whole group with stability being best in cluster 2 (71%) and worst in cluster 4 (25%). In an independent validation cohort, the classifier identified the same 5 clusters with similar patient distribution and characteristics. INTERPRETATION: Statistical cluster analysis can identify distinct phenotypes with specific outcomes. Cluster membership can be determined using a classifier, but when treatment is optimised, cluster stability is poor.
format Online
Article
Text
id pubmed-4109965
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41099652014-07-29 Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability Newby, Chris Heaney, Liam G. Menzies-Gow, Andrew Niven, Rob M. Mansur, Adel Bucknall, Christine Chaudhuri, Rekha Thompson, John Burton, Paul Brightling, Chris PLoS One Research Article BACKGROUND: Severe refractory asthma is a heterogeneous disease. We sought to determine statistical clusters from the British Thoracic Society Severe refractory Asthma Registry and to examine cluster-specific outcomes and stability. METHODS: Factor analysis and statistical cluster modelling was undertaken to determine the number of clusters and their membership (N = 349). Cluster-specific outcomes were assessed after a median follow-up of 3 years. A classifier was programmed to determine cluster stability and was validated in an independent cohort of new patients recruited to the registry (n = 245). FINDINGS: Five clusters were identified. Cluster 1 (34%) were atopic with early onset disease, cluster 2 (21%) were obese with late onset disease, cluster 3 (15%) had the least severe disease, cluster 4 (15%) were the eosinophilic with late onset disease and cluster 5 (15%) had significant fixed airflow obstruction. At follow-up, the proportion of subjects treated with oral corticosteroids increased in all groups with an increase in body mass index. Exacerbation frequency decreased significantly in clusters 1, 2 and 4 and was associated with a significant fall in the peripheral blood eosinophil count in clusters 2 and 4. Stability of cluster membership at follow-up was 52% for the whole group with stability being best in cluster 2 (71%) and worst in cluster 4 (25%). In an independent validation cohort, the classifier identified the same 5 clusters with similar patient distribution and characteristics. INTERPRETATION: Statistical cluster analysis can identify distinct phenotypes with specific outcomes. Cluster membership can be determined using a classifier, but when treatment is optimised, cluster stability is poor. Public Library of Science 2014-07-24 /pmc/articles/PMC4109965/ /pubmed/25058007 http://dx.doi.org/10.1371/journal.pone.0102987 Text en © 2014 Newby et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Newby, Chris
Heaney, Liam G.
Menzies-Gow, Andrew
Niven, Rob M.
Mansur, Adel
Bucknall, Christine
Chaudhuri, Rekha
Thompson, John
Burton, Paul
Brightling, Chris
Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
title Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
title_full Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
title_fullStr Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
title_full_unstemmed Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
title_short Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
title_sort statistical cluster analysis of the british thoracic society severe refractory asthma registry: clinical outcomes and phenotype stability
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109965/
https://www.ncbi.nlm.nih.gov/pubmed/25058007
http://dx.doi.org/10.1371/journal.pone.0102987
work_keys_str_mv AT newbychris statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT heaneyliamg statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT menziesgowandrew statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT nivenrobm statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT mansuradel statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT bucknallchristine statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT chaudhurirekha statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT thompsonjohn statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT burtonpaul statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT brightlingchris statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability
AT statisticalclusteranalysisofthebritishthoracicsocietysevererefractoryasthmaregistryclinicaloutcomesandphenotypestability